Pharmacological therapy of episodic ataxia type 2: a placebo-controlled comparison of the efficacy of 4-aminopyridine sustained-release (Fampyra) and acetazolamide (Acemit)
Phase of Trial: Phase III
Latest Information Update: 28 May 2019
At a glance
- Drugs Fampridine (Primary) ; Acetazolamide
- Indications Ataxia
- Focus Therapeutic Use
- 26 Oct 2016 Status changed from recruiting to completed.
- 25 Sep 2013 New source identified and integrated (German Clinical Trials Register; DRKS00005258).
- 11 Jun 2013 New trial record